| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, FL Baehner, ... New England Journal of Medicine 351 (27), 2817-2826, 2004 | 7183 | 2004 |
| A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes RM Neve, K Chin, J Fridlyand, J Yeh, FL Baehner, T Fevr, L Clark, ... Cancer cell 10 (6), 515-527, 2006 | 3743 | 2006 |
| Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer S Paik, G Tang, S Shak, C Kim, J Baker, W Kim, M Cronin, FL Baehner, ... Journal of clinical oncology 24 (23), 3726-3734, 2006 | 3120 | 2006 |
| The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ... Annals of oncology 26 (2), 259-271, 2015 | 2665 | 2015 |
| Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a … KS Albain, WE Barlow, S Shak, GN Hortobagyi, RB Livingston, IT Yeh, ... The lancet oncology 11 (1), 55-65, 2010 | 1597 | 2010 |
| Breast cancer prognostic classification in the molecular era: the role of histological grade EA Rakha, JS Reis-Filho, F Baehner, DJ Dabbs, T Decker, V Eusebi, ... Breast cancer research 12, 1-12, 2010 | 1216 | 2010 |
| Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists S Badve, DJ Dabbs, SJ Schnitt, FL Baehner, T Decker, V Eusebi, SB Fox, ... Modern pathology 24 (2), 157-167, 2011 | 919 | 2011 |
| Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with … M Dowsett, J Cuzick, C Wale, J Forbes, EA Mallon, J Salter, E Quinn, ... J Clin Oncol 28 (11), 1829-1834, 2010 | 834 | 2010 |
| A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling EA Klein, MR Cooperberg, C Magi-Galluzzi, JP Simko, SM Falzarano, ... European urology 66 (3), 550-560, 2014 | 726 | 2014 |
| The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade B Weigelt, FL Baehner, JS Reis‐Filho The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010 | 645 | 2010 |
| A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast LJ Solin, R Gray, FL Baehner, SM Butler, LL Hughes, C Yoshizawa, ... Journal of the National Cancer Institute 105 (10), 701-710, 2013 | 562 | 2013 |
| β1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and … CC Park, H Zhang, M Pallavicini, JW Gray, F Baehner, CJ Park, MJ Bissell Cancer research 66 (3), 1526-1535, 2006 | 432 | 2006 |
| Validation study of a quantitative multigene reverse transcriptase–polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer RG Gray, P Quirke, K Handley, M Lopatin, L Magill, FL Baehner, ... Journal of clinical oncology 29 (35), 4611-4619, 2011 | 430 | 2011 |
| Breast cancer growth prevention by statins MJ Campbell, LJ Esserman, Y Zhou, M Shoemaker, M Lobo, E Borman, ... Cancer research 66 (17), 8707-8714, 2006 | 409 | 2006 |
| Prognostic utility of the 21-gene assay in hormone receptor–positive operable breast cancer compared with classical clinicopathologic features LJ Goldstein, R Gray, S Badve, BH Childs, C Yoshizawa, S Rowley, ... Journal of Clinical Oncology 26 (25), 4063, 2008 | 397 | 2008 |
| Bladder cancer outcome and subtype classification by gene expression E Blaveri, JP Simko, JE Korkola, JL Brewer, F Baehner, K Mehta, ... Clinical Cancer Research 11 (11), 4044-4055, 2005 | 372 | 2005 |
| Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus … MJ O'Connell, I Lavery, G Yothers, S Paik, KM Clark-Langone, M Lopatin, ... Journal of clinical oncology 28 (25), 3937, 2010 | 345 | 2010 |
| Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome MJ Campbell, NY Tonlaar, ER Garwood, D Huo, DH Moore, AI Khramtsov, ... Breast cancer research and treatment 128, 703-711, 2011 | 308 | 2011 |
| Comparison of the performance of 6 prognostic signatures for estrogen receptor–positive breast cancer: a secondary analysis of a randomized clinical trial I Sestak, R Buus, J Cuzick, P Dubsky, R Kronenwett, C Denkert, S Ferree, ... JAMA oncology 4 (4), 545-553, 2018 | 307 | 2018 |
| Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study LJ Solin, R Gray, LL Hughes, WC Wood, MA Lowen, SS Badve, ... Journal of Clinical Oncology 33 (33), 3938, 2015 | 279 | 2015 |
Stewart WolmarkStewart Wolmark is chairman of the National Surgical Adjuvant Breast Project and a professor ofVerified email at pcc.edu
